Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does graft-versus-host disease attack epithelial stem cells?

G E Sale1

  • 1Department of Pathology Fred Hutchinson Cancer Research Center, Seattle, WA 98104, USA. gsale@fred.fhcrc.org

Molecular Medicine Today
|March 1, 1996
PubMed
Summary

Graft-versus-host disease (GvHD) involves donor immune cells attacking the host, potentially targeting tumors. Understanding GvHD mechanisms is key to separating its anti-tumor effects from harmful side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.

Bone marrow transplantation·2014
Same author

Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells.

Oncogene·2013
Same author

Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results.

Transplantation proceedings·2002
Same author

Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia.

Blood·2001
Same author

Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells.

Transplantation·2000
Same author

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

Blood·1999

Area of Science:

  • Immunology
  • Oncology
  • Stem Cell Biology

Background:

  • Graft-versus-host disease (GvHD) occurs when donor lymphocytes attack host tissues like skin, liver, and gut.
  • Paradoxically, GvHD can also target and destroy host tumor cells, a phenomenon known as the graft-versus-tumor (GvT) effect.
  • The specific targeting of normal tissues in epithelial stem cell niches suggests GvHD might be an aberrant form of a natural growth regulation system.

Purpose of the Study:

  • To explore the mechanisms underlying GvHD.
  • To investigate the potential for separating the beneficial GvT effect from the detrimental GvHD response.
  • To understand the relationship between GvHD and physiological growth control.

Main Methods:

  • Review of existing literature on GvHD and GvT mechanisms.

Related Experiment Videos

  • Analysis of GvHD target tissue distribution in relation to stem cell sites.
  • Conceptual framework development for understanding GvHD as a dysregulated biological process.

    • Main Results:

    • GvHD involves donor lymphocytes attacking host tissues, with a notable preference for epithelial stem cell sites.
    • The GvT effect, where GvHD targets tumors, presents a therapeutic opportunity.
    • GvHD's peculiar tissue targeting suggests a link to normal physiological growth control mechanisms.

    Conclusions:

    • Further research into GvHD mechanisms is crucial for developing strategies to harness the GvT effect.
    • Separating therapeutic GvT from pathological GvHD requires a deeper understanding of the underlying immunological and biological processes.
    • GvHD may represent a critical area for investigating the interplay between immune responses and tissue regeneration/homeostasis.